20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
Palantir Technologies Inc. (NYSE:PLTR) inked a pact with Fondazione Policlinico Universitario A. Gemelli IRCCS, (Policlinico Gemelli), to implement AI-based digital medicine research solutions.
The companies will work towards the development of AI-based digital medicine solutions for healthcare research in Italy.
Policlinico Gemelli's digital research center, Generator RWD, will utilize Palantir Foundry as one of the key enabling platforms to manage the full scale and complexity of healthcare data.
"More and more of the industry is wielding this power to discover novel therapies, improve patient care and increase treatment efficiency and effectiveness," said Andrea Galvagni, Head of Italy at Palantir.
During its Q2 results last month, CEO Alex Karp said PLTR's AI platform has added customers across more than 100 organizations in less than three months.
"The demand for AIP is unlike anything we have seen in the past 20 years. We are currently in discussions with more than 300 additional enterprises to deploy AIP within their organizations," Karp said then.
Also Read: Palantir's AI Euphoria May Fade Due To Lack Of Monetization Strategy: Analyst
Price Action: PLTR shares are trading higher by 1.25% to $15.40 on the last check Friday.
20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!